FDA, NIH, 10 pharmaceutical companies and five non-profit organizations have partnered to accelerate development of gene therapies for the 30 million Americans who suffer from a rare disease.
Read more: FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases